KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) EBIT Margin Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 660.00
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn -179.00
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn -138.00
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -6,345.00
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 1,648.00
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 360.00
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 2,760.00
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn -103.00
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 -179.00
Dec 28, 2025 6,570.00
Sep 28, 2025 690.00
Jun 29, 2025 -83.00
Mar 30, 2025 60.00
Dec 29, 2024 -7,214.00
Sep 29, 2024 -447.00
Jun 30, 2024 181.00
Mar 31, 2024 28.00
Dec 31, 2023 3,993.00
Oct 1, 2023 38.00
Jul 2, 2023 782.00
Apr 2, 2023 542.00
Oct 2, 2022 -181.00
Jul 3, 2022 -742.00
Apr 3, 2022 -761.00
Oct 3, 2021 93.00
Jul 4, 2021 481.00
Apr 4, 2021 157.00
Jan 3, 2021 1,652.00
Sep 27, 2020 -70.00
Jun 28, 2020 -424.00
Mar 29, 2020 154.00
Dec 29, 2019 15.00
Sep 29, 2019 96.00
Jun 30, 2019 37.00
Mar 31, 2019 -166.00
Dec 30, 2018 489.00
Sep 30, 2018 406.00
Jul 1, 2018 -237.00
Apr 1, 2018 -209.00
Dec 31, 2017 -1,050.00
Oct 1, 2017 -655.00
Jul 2, 2017 -208.00
Apr 2, 2017 -22.00
Jan 1, 2017 -3,966.00
Oct 2, 2016 245.00
Jul 3, 2016 247.00
Apr 3, 2016 -37.00
Jan 3, 2016 4,323.00
Sep 27, 2015 -305.00
Jun 28, 2015 -298.00
Mar 29, 2015 -40.00
Dec 28, 2014 -58.00
Sep 28, 2014 246.00
Jun 29, 2014 229.00
Mar 30, 2014 292.00
Dec 29, 2013 -146.00
Sep 29, 2013 250.00
Jun 30, 2013 41.00
Mar 31, 2013 -4.00
Dec 30, 2012 1,438.00
Sep 30, 2012 75.00
Jul 1, 2012 540.00
Apr 1, 2012 -17.00
Jan 1, 2012 -5,852.00
Oct 2, 2011 -235.00
Jul 3, 2011 -550.00
Apr 3, 2011 -205.00
Jan 2, 2011 5,451.00
Oct 3, 2010 -142.00
Jul 4, 2010 -55.00
Apr 4, 2010 -44.00